Request For Predictable NIH Funding Growth Met By Spending Caps
This article was originally published in The Tan Sheet
The best way to accelerate medical cures, National Institutes of Health Director Francis Collins tells the congressional 21st Century Cures coalition, is to assure that NIH researchers are supplied with a steady, predictable source of grant funding.
You may also be interested in...
A study in the Journal of American Medical Association says that the U.S. contribution to global biomedical research funding is on the decline, which could have big implications for domestic innovation.
A study in the most recent issue of JAMA shows that the U.S. contribution to biomedical research funding is on the decline and may result in decreased innovation, should other funding sources not be found.
CDRH Director Jeffrey Shuren participated in the first roundtable of a newly launched House Energy and Commerce Committee initiative to accelerate drug and device development. He emphasized the device center’s recent proposals to minimize pre-market data collection with postmarket controls, and supported the promise of clinical trial networks.